Association comprising a PPAR ligand and antioxidant agent and use thereof for treating obesity

摘要

Disclosed is an association comprising 1) an antioxidant agent and 2) a mixed PPAR ligand for the alpha and gamma receptor sub-types, or a selective PPAR ligand for the alpha receptor sub-type and a selective PPAR ligand for the gamma receptor sub-type. Also disclosed is a pharmaceutical comprising as the active ingredient one or more PPAR ligands (such as rosiglitazone) in association with an antioxidant agent (such as coenzyme Q10 or ubiquinone) as described above for use in the manufacture of a medicament for the treatment and or prevention of obesity.